Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small, dense LDL.
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
PURPOSE OF REVIEW: The magnitude of the contribution of serum triglycerides to cardiovascular disease risk and the mechanisms by which triglyceride-rich lipoproteins exert their effect on the vascular wall are largely unknown. Postprandial lipemia likewise has been linked to atherosclerosis, but large prospective studies assessing the magnitude of this association are also lacking. Hypertriglyceridemia is characterized by the presence of cholesterol-rich remnant-like lipoproteins and small dense LDL particles, both of which are believed to contribute to cardiovascular disease risk. RECENT FINDINGS: Several large prospective cohort studies and a meta-analysis have been published recently, investigating the association of fasting and nonfasting serum triglycerides with cardiovascular disease. Fasting triglycerides increase the adjusted hazard ratios for cardiovascular disease risk 1.7 x (comparing upper with lower tertile), and nonfasting levels around 2.0 x. Measurement of nonfasting triglycerides may be more feasible and more informative, but standardization of a test meal is necessary. For clinical practice, the concentration of the atherogenic lipoprotein subfractions in hypertriglyceridemia may be reflected best by measuring apolipoprotein B. SUMMARY: Nonfasting triglyceride levels may replace fasting levels in assessing cardiovascular disease risk once standard reference values have been developed. Several atherogenic lipoprotein subfractions can be measured by including apolipoprotein B in addition to HDL, (nonfasting) triglycerides and LDL cholesterol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prospective studies have indicated that, compared with fasting levels, nonfasting serum triglyceride levels may be a better or similar predictor of CVD events in the general population (15-18).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [18]
In the citing paper
“On a general note, given the multiple tests there was the potential for false positive findings; however, if corrected for multiple testing and thus reducing the false positive error rate, the false negative error rate would increase which could lead to missing possible important findings 29.”
From Irregular consumption of energy intake in meals is associated with a higher cardiometabolic risk in adults of a British birth cohort (2014) · cites this paper as [29]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Walldius, G., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W., & Steiner, E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07098-2 · Cited by 1,229
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
de Graaf, J., Hak-Lemmers, H. L., Hectors, M. P., Demacker, P. N., Hendriks, J. C., & Stalenhoef, A. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Self-citationOtvos, J. D., Collins, D., Freedman, D. S., Shalaurova, I., Schaefer, E. J., McNamara, J. R., Bloomfield, H. E., & Robins, S. J. (2006) · Circulation · doi:10.1161/circulationaha.105.565135 · Cited by 547
Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514
BARTER, P. J., BALLANTYNE, C. M., CARMENA, R., CABEZAS, M. C., CHAPMAN, M. J., COUTURE, P., DE GRAAF, J., DURRINGTON, P. N., FAERGEMAN, O., FROHLICH, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 464
Self-citationMahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447
Mora, S., Szklo, M., Otvos, J. D., Greenland, P., Psaty, B. M., Goff, D. C., O’Leary, D. H., Saad, M. F., Tsai, M. Y., & Sharrett, A. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.007 · Cited by 380
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Circulation · doi:10.1161/01.cir.0000145615.33955.83 · Cited by 358
Phillips, N. R., Waters, D., & Havel, R. J. (1993) · Circulation · doi:10.1161/01.cir.88.6.2762 · Cited by 344
Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., & Kane, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1767 · Cited by 340
Vakkilainen, J., Steiner, G., Ansquer, J.-C., Aubin, F., Rattier, S., Foucher, C., Hamsten, A., & Taskinen, M.-R. (2003) · Circulation · doi:10.1161/01.cir.0000057982.50167.6e · Cited by 270
Boquist, S., Ruotolo, G., Tang, R., Björkegren, J., Bond, M. G., de Faire, U., Karpe, F., & Hamsten, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.723 · Cited by 255
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255
Anber, V., Griffin, B. A., McConnell, M., Packard, C. J., & Shepherd, J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05842-x · Cited by 238
Postprandial hyperlipidemia and remnant lipoproteins.
Havel, R. J. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199404000-00006 · Cited by 209
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 201
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Management of Primary Hyperlipidemia
Havel, R. J., & Rapaport, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322207 · Cited by 188
Galeano, N. F., Milne, R., Marcel, Y. L., Walsh, M. T., Levy, E., Ngu'yen, T. D., Gleeson, A., Arad, Y., Witte, L., & al-Haideri, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42379-9 · Cited by 181
Changes in triglyceride levels and risk for coronary heart disease in young men.
Tirosh, A., Rudich, A., Shochat, T., Tekes-Manova, D., Israeli, E., Henkin, Y., Kochba, I., & Shai, I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00007 · Cited by 151
Saha, S. A., Kizhakepunnur, L. G., Bahekar, A., & Arora, R. R. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.011 · Cited by 137
de Graaf, J., Hendriks, J. C., Demacker, P. N., & Stalenhoef, A. F. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.5.712 · Cited by 132
Self-citationPackard, C. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236367.42755.c1 · Cited by 127
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Blanche, P. J., Holl, L. G., & Krauss, R. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000053385.64132.2d · Cited by 126
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Holl, L. G., Krauss, R. M., Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Patricia, J., & Blanche, P. J. (2015) · Cited by 122
Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
(2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00003 · Cited by 118
Skoglund-Andersson, C., Tang, R., Bond, M. G., de Faire, U., Hamsten, A., & Karpe, F. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2422 · Cited by 104
Chung, B. H., Tallis, G., Yalamoori, V, Anantharamaiah, G. M., & Segrest, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.622 · Cited by 97
Brenninkmeijer, B. J., Stuyt, P. M., Demacker, P. N., Stalenhoef, A. F., & van 't Laar, A. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38689-2 · Cited by 93
Self-citationCombined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia
Stalenhoef, A. F. H., Casparie, A. F., Demacker, P. N. M., Stouten, J. T. J., Lutterman, J. A., & Laar, A. V. (1981) · Metabolism · doi:10.1016/0026-0495(81)90072-x · Cited by 91
Self-citationNakamura, T., Takano, H., Umetani, K., Kawabata, K.-I., Obata, J.-E., Kitta, Y., Kodama, Y., Mende, A., Ichigi, Y., Fujioka, D., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.012 · Cited by 90
Imke, C., Rodriguez, B. L., Grove, J. S., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 90
Demacker, P. N. M., Veerkamp, M. J., Bredie, S. J. H., Marcovina, S. M., Graaf, J. D., & Stalenhoef, A. F. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00432-9 · Cited by 89
Self-citationPatel, V. V., Rho, R. W., Gerstenfeld, E. P., Hsia, H. H., Callans, D. J., & Marchlinski, F. E. (2004) · Circulation · doi:10.1161/01.cir.0000145542.24347.18 · Cited by 86
Stalenhoef, A. F., Malloy, M. J., Kane, J. P., & Havel, R. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112632 · Cited by 70
Self-citationArsenault, B. J., Lemieux, I., Despres, J.-P., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., & Boekholdt, S. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm390 · Cited by 63
Karpe, F. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00700-0 · Cited by 50
Marcoux, C., Hopkins, P. N., Wang, T., Leary, E. T., Nakajima, K., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33455-6 · Cited by 43
High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
de Graaf, J., van der Vleuten, G. M., ter Avest, E., Dallinga-Thie, G. M., & Stalenhoef, A. F. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1973 · Cited by 28
Self-citationQuality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size*
Wierzbicki, A. S. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01571.x · Cited by 12
de Graaf, J., Hendriks, J. C., Swinkels, D. W., Demacker, P. N. M., & Stalenhoef, A. F. H. (1993) · PubMed · Cited by 9
Self-citation
Research works printed but not linked: 1
- de Graaf, 1993, Artery, 20, 201
Cited by
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
Self-citationDekker, M. J., Su, Q., Baker, C., Rutledge, A. C., & Adeli, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2010 · Cited by 420
D. Kolovou, G., P. Mikhailidis, D., Kovar, J., Lairon, D., G. Nordestgaard, B., Chye Ooi, T., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111795495549 · Cited by 306
Dietary Triacylglycerol Structure and Its Role in Infant Nutrition
Innis, S. M. (2011) · Advances in Nutrition · doi:10.3945/an.111.000448 · Cited by 277
“Most studies on dietary TG structure in adults have focused on postprandial plasma TG clearance, explained in part by the atherogenicity of TG remnants and evidence that elevated TG is an independent risk factor for cardiovascular disease (6,58,59,82,83).”
Background
Metadata
- Authors
- Stalenhoef, A. F., & de Graaf, J.
- Affiliations
- Radboud University Medical Center (NL)
- Corresponding author
- Stalenhoef, Anton FH
- Venue
- Current Opinion in Lipidology
- Published
- 2008-08
- Volume
- 19
- Issue
- 4
- Pages
- 355-361
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2007948928
- Cited by
- 121
- References
- 54
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 10 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 8 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 9
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Lipidology (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- serum triglycerides, fasting triglycerides, cardiovascular risk, small dense LDL, hypertriglyceridemia, postprandial lipemia, apolipoprotein B, atherosclerosis
- MeSH terms
- Cardiovascular Diseases, Fasting, Humans, Cholesterol, LDL, Risk Factors, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.